Brief: Abbisko Cayman Says Unit Got Regulatory Approval From Food & Drug Administration Of U.S.
25/10/2021 01:00
Oct 25 (Reuters) - Abbisko Cayman Ltd 2256.HK :
* UNIT GOT REGULATORY APPROVAL FROM FOOD & DRUG
ADMINISTRATION OF
U.S. TO INITIATE FIRST-IN-HUMAN PHASE I CLINICAL STUDY FOR
ABSK061
Source text for Eikon: ID:nHKS7sfZvg
Further company coverage: 2256.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Abbisko Medicine
See all newsChina's Abbisko jumps on positive clinical trial results for achondroplasia drug
Brief: Abbisko Cayman Says Unit Completes First Patient Dosing In Phase I Trial Of ABSK211
Brief: Abbisko Cayman Gets IND Clearance From FDA For Oral Small Molecule Pan-Kras Inhibitor ABSK211
HK-listed Abbisko hits 7-week peak on AstraZeneca tie-up
Brief: Abbisko Therapeutics And Astrazeneca Enter A Strategic Collaboration